Does MOGAMULIZUMAB-KPKC Cause Dermatitis exfoliative generalised? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Dermatitis exfoliative generalised have been filed in association with MOGAMULIZUMAB-KPKC. This represents 0.6% of all adverse event reports for MOGAMULIZUMAB-KPKC.
7
Reports of Dermatitis exfoliative generalised with MOGAMULIZUMAB-KPKC
0.6%
of all MOGAMULIZUMAB-KPKC reports
2
Deaths
2
Hospitalizations
How Dangerous Is Dermatitis exfoliative generalised From MOGAMULIZUMAB-KPKC?
Of the 7 reports, 2 (28.6%) resulted in death, 2 (28.6%) required hospitalization, and 1 (14.3%) were considered life-threatening.
Is Dermatitis exfoliative generalised Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MOGAMULIZUMAB-KPKC. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does MOGAMULIZUMAB-KPKC Cause?
Rash (177)
Disease progression (107)
Drug eruption (62)
Pruritus (58)
Infusion related reaction (54)
Death (45)
Fatigue (44)
Chills (40)
Inappropriate schedule of product administration (39)
Pyrexia (39)
What Other Drugs Cause Dermatitis exfoliative generalised?
ALLOPURINOL (192)
DUPILUMAB (162)
METHOTREXATE (151)
SULFAMETHOXAZOLE\TRIMETHOPRIM (140)
AMOXICILLIN (122)
ADALIMUMAB (113)
PANTOPRAZOLE (105)
SECUKINUMAB (96)
VANCOMYCIN (92)
AMLODIPINE (91)
Which MOGAMULIZUMAB-KPKC Alternatives Have Lower Dermatitis exfoliative generalised Risk?
MOGAMULIZUMAB-KPKC vs MOLNUPIRAVIR
MOGAMULIZUMAB-KPKC vs MOLSIDOMINE
MOGAMULIZUMAB-KPKC vs MOMELOTINIB
MOGAMULIZUMAB-KPKC vs MOMETASONE
MOGAMULIZUMAB-KPKC vs MOMETASONE FUROATE